Humana Reports Third Quarter 2021 Financial Results; Revises Full Year 2021 EPS Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Humana (HUM) PT Lowered to $480 at Cantor Fitzgerald
November 3, 2021 11:11 AM EDTCantor Fitzgerald analyst Steven Halper lowered the price target on Humana (NYSE: HUM) to $480.00 (from $508.00) while maintaining an Overweight rating.
The analyst commented, ". We reiterate our Overweight rating on HUM shares but reduce our price target to $480 from $508. This morning, November 3, the company reported 3Q21 results which on... More
Humana (HUM) Tops Q3 EPS by 17c, Updates FY Guidance
November 3, 2021 6:35 AM EDTHumana (NYSE: HUM) reported Q3 EPS of $4.83, $0.17 better than the analyst estimate of $4.66. Revenue for the quarter came in at $20.7 billion versus the consensus estimate of $20.91 billion.
GUIDANCE:
Humana sees Q4 2021 EPS of $20.50, versus the consensus of... More
